- Home
- KNDI vs JSPR Comparison
KNDI vs JSPR Comparison
Compare KNDI & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- JSPR
- Stock Information
- Founded
- KNDI 2002
- JSPR 2018
- Country
- KNDI China
- JSPR United States
- Employees
- KNDI N/A
- JSPR N/A
- Industry
- KNDI Auto Manufacturing
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KNDI Consumer Discretionary
- JSPR Health Care
- Exchange
- KNDI Nasdaq
- JSPR Nasdaq
- Market Cap
- KNDI 101.7M
- JSPR 68.4M
- IPO Year
- KNDI N/A
- JSPR N/A
- Fundamental
- Price
- KNDI $1.20
- JSPR $2.34
- Analyst Decision
- KNDI
- JSPR Buy
- Analyst Count
- KNDI 0
- JSPR 11
- Target Price
- KNDI N/A
- JSPR $28.00
- AVG Volume (30 Days)
- KNDI 111.5K
- JSPR 395.5K
- Earning Date
- KNDI 11-17-2025
- JSPR 11-07-2025
- Dividend Yield
- KNDI N/A
- JSPR N/A
- EPS Growth
- KNDI N/A
- JSPR N/A
- EPS
- KNDI N/A
- JSPR N/A
- Revenue
- KNDI $104,035,613.00
- JSPR N/A
- Revenue This Year
- KNDI N/A
- JSPR N/A
- Revenue Next Year
- KNDI N/A
- JSPR N/A
- P/E Ratio
- KNDI N/A
- JSPR N/A
- Revenue Growth
- KNDI N/A
- JSPR N/A
- 52 Week Low
- KNDI $0.89
- JSPR $2.22
- 52 Week High
- KNDI $1.81
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- KNDI 41.01
- JSPR 41.70
- Support Level
- KNDI $1.21
- JSPR $2.30
- Resistance Level
- KNDI $1.29
- JSPR $2.57
- Average True Range (ATR)
- KNDI 0.06
- JSPR 0.15
- MACD
- KNDI 0.00
- JSPR -0.00
- Stochastic Oscillator
- KNDI 18.42
- JSPR 12.50
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.